We look at some of the top companies that are investigating CAR-T therapies in clinical trials for autoimmune diseases.
The innate immune system, located in the skin and the mucous membranes is a highly complex physical and chemical barrier providing a first line defense ...
Mayo Clinic researchers have identified a protein that cancer cells use to shut down the body's immune response, a discovery that could help scientists develop new treatments that make cancer ...
Second quarter 2026 total global revenue of approximately $240 million, including BRIUMVI U.S. net product revenue of approximately $228 million ...
Following planned data collection, DURIPANC Primary Endpoint analysis is anticipated to begin in December 2026 and topline results are anticipated in Q1 2027. DURIPANC’s primary endpoint is Clinical ...
This indication is approved under accelerated approval based on reduction of proteinuria. It has not been established whether VOYXACT slows kidney function decline over the long-term in patients with ...
Low arginine levels may allow cancer cells and viruses to slip past the immune system by reducing production of a crucial ...
Bispecific antibodies, which bind to two targets, are sweeping into the clinic and are prompting even more elaborate versions ...
DRC Ebola outbreak 2026 has officially become the second-largest in recorded history, with 3,532 confirmed cases and 1,556 ...
The Hearty Soul on MSN
How long poop stays in your body could have a surprisingly big impact on your disease risk
Your stool transit time shapes your gut microbiome, bile acid levels, and disease risk. The post How Long Poop Stays in Your ...
Clinical data from the HERCULES trial show that tolebrutinib reduces six-month confirmed disability progression by 31% in non ...
Chronic hepatitis B (CHB) remains a major global challenge. Current therapies suppress HBV but rarely achieve functional cure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results